Expression of thrombospondin-1 in ischemia-induced retinal neovascularization

American Journal of Pathology

Volumn 154, Issue 2, 1999, Pages 343-354

  Suzuma, Kiyoshi ^a   Takagi, Hitoshi ^a   Otani, Atsushi ^a   Oh, Hideyasu ^a   Honda, Yoshihito ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION;

EID: 0032914336     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65281-9     Document Type: Article

References (78)

1. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-mitiated angiogenesis. Nature 1992, 359:843-845
2. Berse B, Brown LF, Van-de-Water L, Dvorak HF, Senger DR Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992, 3:211-220
3. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309
4. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE: Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995, 92:10457-10461
5. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LE: Oligodeoxynucleotides inhibit retinal neovascularizaton in a murine model of proliferate retinopathy. Proc Natl Acad Sci USA 1996, 93:4851-4856
6. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, Miller JW: Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 1996, 114:66-71
7. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP: Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996, 103:1820-1828
8. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al: Vascular endothenal growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 331:1480-1487
9. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT: Increased vascular endothelial growth factor levels in the vitreous of eyes win proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450
10. Pe'er J, Folberg R, Itin A, Gnessin H, Memo I, Keshet E: Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 1996, 80:241-245
11. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR: Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996, 37:855-868
12. Lawler JW, Slayter HS, Coligan JE: Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 1978, 253:8609-8616
13. McPherson J, Sage H Bornstein P: Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture; apparent identity with platelet thrombospondin. J Biol Chem 1981, 256: 11330-11336
14. Raugi GJ, Mumby SM, Abbott-Brown D, Bornstein P: Thrombospondin: synthesis and secretion by cells in culture. J Cell Biol 1982, 95:351-354
15. Jaffe EA, Ruggiero JT, Leung LK, Doyle MJ, McKeown-Longo PJ, Mosher DF: Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 1983, 80:998-1002
16. Jaffe EA, Ruggiero JT, Falcone DJ: Monocytes and macrophages synthesize and secrete thrombospondin. Blood 1985, 65:79-84
17. Reed MJ, Iruela-Arispe L, O'Brien ER, Truong T, LaBell T, Bornstein P, Sage EH: Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1. Am J Pathol 1995, 147:1068-1080
18. Majack RA, Cook SC, Bornstein P: Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cel Biol 1985, 101:1059-1070
19. Majack RA, Cook SC, Bornstein P: Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci USA 1986, 83:9050-9054
20. Majack RA, Goodman LV, Dixit VM: Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol 1988, 106:415-422
21. Phan SH, Dillon RG, McGarry BM, Dixit VM: Stimulation of fibroblast proliferation by thrombospondin. Bochem Biophys Res Commun 1989, 163:56-63
22. Castle VP, Ou X, O'Rourke K, Dixit VM: High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum-and anchorage-independent growth. J Biol Chem 1993, 268:2899-2903
23. Rastinejad F, Polverini PJ, Bouck NP: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989, 56:345-355
24. Good DJ, Polverini PJ, Rastinejad F, Le-Beau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990, 87: 6624-6628
25. Bagavandoss P, Wilks JW: Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem Biophys Res Commun 1990, 170:867-872
26. Iruela-Arispe ML, Bornstein P, Sage H: Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 1991, 88:5026-5030
27. Tarabolett G, Roberts D, Liotta LA, Giavazzi R: Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth a potential angiogenesis regulatory factor. J Cell Biol 1990, 111:765-772
28. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N: Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993, 122:497-511
29. Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF, Bouck N: Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 1995, 217:326-332
30. Tolsma SS, Stack MS, Bouck N: Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1. Microvasc Res 1997, 54:13-26
31. Dawson DW, Pearce SF, Zhong R, Silverstein RL, Frazier WA, Bouck NP: CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 1997, 138:707-717
32. Tuszynski GP, Rothman V, Murphy A, Siegler K, Smith L, Smith S, Karczewski J, Knudsen KA: Thrombospondin promotes cell-substratum adhesion. Science 1987, 236:1570-1573
33. Roberts DD, Sherwood JA, Ginsburg V: Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol 1987, 104:131-139
34. Lawler J, Weinstein R, Hynes RO: Cell attachment to thrombospondin the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 1988, 107:2351-2361
35. Gou, Krutzsch HC, Negre E, Zabrenetzky VS, Roberts DD: Heparin-binding peptides from the type I repeats of thrombospondin structural requirements for heparin binding and promotion of melaroma cell adhesion and chemotaxis. J Biol Chem 1992, 267:19349-19355
36. Adams JC, Lawler J: Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1. Mol Biol Cell 1994, 5:423-437
37. Murphy-Ullrich JE, Hook M: Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol 1989, 109:1309-1319
38. Murphy-Ullrich JE, Schultz-Cherry S, Hook M: Transforming growth factor-β complexes with thrombospondin. Mol Biol Cell 1992, 3:181-188
39. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE: The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β. J Biol Chem 1994, 269:26783-26788
40. Majack RA, Mildbrandt J, Dixit VM: Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J Biol Chem 1987, 262:8821-8825
41. Donoviel DB, Amacher SL, Judge KW, Bornstein P: Thrombospondin gene expression is associated with mitogenesis in 3T3 cells: induction by basic fibroblast growth factor. J Cell Physiol 1990, 145:16-23
42. Janat MF, Liau G: Transforming growth factor β1 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells. J Cell Physiol 1992, 150:232-242
43. Framson P, Bornstein P: A serum response element and a binding site for NF-Y mediate the serum response of the human thrombospondin 1 gene. J Biol Chem 1993, 268:4989-4996
44. Dameron KM, Volpert OV, Tainsky MA, Bouck N: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994, 265:1582-1584
45. Volpert OV, Dameron KM, Bouck N: Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene 1997, 14:1495-1502
46. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP: Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994, 94:1320-1327
47. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995, 92:905-909
48. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111
49. Kobayashi S, Eden-McCutchan F, Framson P, Bornstein P: Partial amino acid sequence of human thrombospondin as determined by analysis of cDNA clones: homology to malarial circumsporozoite proteins. Biochemistry 1986, 25:8418-8425
50. Laherty CD, O'Rourke K Wolf FW, Katz R, Seldin MF, Dixit VM: Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. J Biol Chem 1992, 267: 3274-3281
51. Cox KH, DeLeon DV, Angerer LM, Angerer RC: Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 1984, 101:485-502
52. Ohtani H, Kuroiwa A, Obinata M, Ooshima A, Nagura H: Identification of type I collagen-producing cells in human gastrointestinal carcinomas by non-radioactive in situ hybridization and immunoelectron microscopy. J Histochem Cytochem 1992, 40:1139-1146
53. Tautz D, Pfeifle C: A non-radioactive in situ hybridization method for the localization of specific RNAs in Drosophila embryos reveals translational control of the segmentation gene hunchback. Chromosoma 1989, 98:81-85
54. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP: Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 1996, 37:2165-2176
55. King GL, Goodman AD Buzney S, Moses A, Kahn CR: Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985, 75:1028-1036
56. Liang P, Parcee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971
57. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL: Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 1995, 44:98-103
58. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD, Steeg PS: Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 1994, 54:6504-6411
59. Sheibani N, Frazier WA: Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc Natl Acad Sci USA 1995, 92:6788-6792
60. Guo N, Krutzsch HC, Inman JK, Roberts DD: Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 1997, 57:1735-1742
61. Diaz-Flores L, Gutierrez R, Varela H: Angiogenesis: an update. Histol Histopathol 1994, 9:807-843
62. Suzuma K, Takagi H, Otani A, Suzuma I, Honda Y: Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization. Microvasc Res 1998, 56:183-191
63. Pierce EA, Foley ED, Smith LE: Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996, 114:1219-1228
64. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, et al: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994, 145:574-584
65. de-Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255:989-991
66. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846
67. Quinn TP, Peters KG, De-Vries C, Ferrara N, Williams LT: Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993, 90:7533-7537
68. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992, 13:18-32
69. Takagi H, King GL, Aiello LP: Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 1996, 45:1016-1023
70. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 1996, 98:2018-2026
71. Guo D, Jia Q, Song HY, Warren RS, Donner DB: Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains: association with endothelial cell proliferation. J Biol Chem 1995, 270:6729-6733
72. Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL: Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform-selective inhibitor. Diabetes 1997, 46:1473-1480
73. Abedi H, Zachary I: Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 1997, 272:15442-15451
74. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 1995, 10:135-147
75. Waitenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994, 269:26988-26995
76. DiPietro LA, Nebgen DR, Polverini PJ: Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J Vasc Res 1994, 31:178-185
77. Taraboletti G, Belotti D, Borsotti P, Vergani V, Rusnati M, Presta M, Giavazzi R: The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. Cell Growth Differ 1997, 8:471-479
78. Tucker RP, The in situ localization of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development 1993, 117:347-358